ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...

The eBook looks at how synthetic biology is revealing hidden bacteriophage targets to combat antibiotic resistance, while pioneering gene therapy strategies are changing the treatment of neurological ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Many non-academic (“industry”) research career options exist within the fields of drug development and medical-device development. Careers within the biotechnology and medical device fields are ...

Hangzhou Diagens Biotechnology has just come through a volatile spell, and the sharp moves now put a simple question on the table for you as a shareholder or potential buyer: Is the current Hong Kong ...

Interview with the Chairman and CEO: MAIA Biotechnology Inc. (NYSEAMERICAN:MAIA) Vlad Vitoc Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir Pharmaceuticals, ...

Biotechnology Innovation Organization president and CEO John F. Crowley visited Rice University Sept. 15 as part of the group’s “BIO on the American Road” tour highlighting regional biotech hubs ...

Aethlon Medical Inc. AEMD stock on Thursday skyrocketed after the company signed an all-stock merger agreement with privately held biotech firm North Immunology Inc. The merger will create a combined ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...

Vir Biotechnology (VIR) announced Wednesday the appointment of David Liu as executive vice president and chief medical officer, effective October 12, 2026. The company said that Liu will be ...